These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 483)

  • 21. Parenteral formulation of Flavopiridol (NSC-649890).
    Dannenfelser RM; Surakitbanharn Y; Tabibi SE; Yalkowsky SH
    PDA J Pharm Sci Technol; 1996; 50(6):356-9. PubMed ID: 9038080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):363-8. PubMed ID: 26687191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cyclodextrins on the chemical stability of drugs.
    Popielec A; Loftsson T
    Int J Pharm; 2017 Oct; 531(2):532-542. PubMed ID: 28596139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.
    Miller KJ; McGovern RM; Ames MM
    Cancer Chemother Pharmacol; 1985; 15(1):49-53. PubMed ID: 3924426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization.
    Cirri M; Maestrelli F; Corti G; Furlanetto S; Mura P
    J Pharm Biomed Anal; 2006 Sep; 42(1):126-31. PubMed ID: 16406448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations.
    Avdeef A
    Eur J Pharm Sci; 2017 Dec; 110():2-18. PubMed ID: 28392495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caffeine complexes with low water solubility: synthesis and dissolution rates of 1:1 and 1:2 caffeine-gentisic acid complexes.
    Higuchi T; Pitman IH
    J Pharm Sci; 1973 Jan; 62(1):55-8. PubMed ID: 4682933
    [No Abstract]   [Full Text] [Related]  

  • 28. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parenteral formulation development for the positive inotropic agent RS-82856: solubility and stability enhancement through complexation and lyophilization.
    Visor GC; Lin LH; Benjamin E; Strickley RG; Gu L
    J Parenter Sci Technol; 1987; 41(4):120-5. PubMed ID: 3668754
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M.
    Krishna G; Hodnick WF; Lang W; Lin X; Karra S; Mao J; Almassian B
    AAPS PharmSciTech; 2001 Aug; 2(3):E14. PubMed ID: 14727873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
    See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
    Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of verapamil in pharmaceutical formulations using atomic emission spectrometry.
    Khalil S; Kelzieh A
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):123-31. PubMed ID: 11682218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complexation of DTPA and EDTA with Cd
    Karak T; Paul RK; Das DK; Boruah RK
    Environ Monit Assess; 2016 Dec; 188(12):670. PubMed ID: 27848112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM; Wu J; Bodor N
    Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y
    Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation kinetics of a substituted carbinolamine in aqueous media.
    Maulding HV; Zoglio MA
    J Pharm Sci; 1977 Aug; 66(8):1175-80. PubMed ID: 19617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits.
    Gordon IL; Kar R; Opfell RW; Wile AG
    Cancer Res; 1987 Oct; 47(19):5070-3. PubMed ID: 3113728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.